您的账号已在其他设备登录,您当前账号已强迫下线,
如非您本人操作,建议您在会员中心进行密码修改

确定
收藏 | 浏览43

The aim of this study was to evaluate the prognostic impact of quantitative estrogen receptor (ER) expression at relapse for ER-positive breast cancer with ER-positive recurrence.A total of 81 patients with ER-positive primary breast cancer and ER-positive paired recurrence were included. ER expression was evaluated as the percentage of tumor cells staining for ER under immunohistochemistry. Samples were defined as ER-high (ER>50

作者:Maria Vittoria, Dieci;Federico, Piacentini;Massimo, Dominici;Claudia, Omarini;Aicha, Goubar;Guido, Ficarra;Pierfranco, Conte;Valentina, Guarneri

来源:Anticancer research 2014 年 34卷 7期

知识库介绍

临床诊疗知识库该平台旨在解决临床医护人员在学习、工作中对医学信息的需求,方便快速、便捷的获取实用的医学信息,辅助临床决策参考。该库包含疾病、药品、检查、指南规范、病例文献及循证文献等多种丰富权威的临床资源。

详细介绍
热门关注
免责声明:本知识库提供的有关内容等信息仅供学习参考,不代替医生的诊断和医嘱。

收藏
| 浏览:43
作者:
Maria Vittoria, Dieci;Federico, Piacentini;Massimo, Dominici;Claudia, Omarini;Aicha, Goubar;Guido, Ficarra;Pierfranco, Conte;Valentina, Guarneri
来源:
Anticancer research 2014 年 34卷 7期
标签:
Metastatic breast cancer estrogen receptor receptor discordance
The aim of this study was to evaluate the prognostic impact of quantitative estrogen receptor (ER) expression at relapse for ER-positive breast cancer with ER-positive recurrence.A total of 81 patients with ER-positive primary breast cancer and ER-positive paired recurrence were included. ER expression was evaluated as the percentage of tumor cells staining for ER under immunohistochemistry. Samples were defined as ER-high (ER>50